| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT01661881 Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma |
Sponsor changed: Dana-Farber Cancer Institute -> Christine Ryan |
| 2026-06-04 | NCT07139873 A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) |
Sponsor changed: Dizal (Jiangsu) Pharmaceutical Co., Ltd. -> Dizal Pharmaceuticals |
| 2026-05-23 | NCT06308978 A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease |
Trial sites expanded: 18 -> 21 locations |
| 2026-05-23 | NCT05139017 A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in… |
Trial sites expanded: 128 -> 131 locations |
| 2026-05-16 | NCT05139017 A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in… |
Trial sites expanded: 124 -> 128 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-08 | NCT07634471 A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | Phase 2/3 | Not Yet Recruiting |
| 2026-05-18 | NCT07593482 Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06522737 | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With… | Lymphoma | Recruiting |
| NCT06970743 | A Study of BGB-16673 Compared to Investigator's Choice in Participants With… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06091254 | A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works… | Follicular Lymphoma (FL) | Recruiting |
| NCT06911502 | A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab… | Follicular Lymphoma | Recruiting |
| NCT06846671 | A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic… | CLL | Recruiting |
| NCT06191744 | Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… | Follicular Lymphoma (FL) | Recruiting |
| NCT06084936 | A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in… | Lymphoma | Recruiting |
| NCT07139873 | A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting |
| NCT05023980 | A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT03336333 | A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT05624554 | A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT04666038 | Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT01886872 | Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in… | Stage I Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT02970318 | A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT04002297 | A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With… | Mantle Cell Lymphoma; Non-Hodgkin Lymphoma | Active, Not Recruiting |
| NCT02972840 | A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously… | Lymphoma, Mantle Cell | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT06193889 | KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With… | Myasthenia Gravis | Recruiting |
| NCT05139017 | A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in… | DLBCL | Recruiting |
| NCT07634471 | A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | Follicular Lymphoma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06854003 | BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC)… | Mantle Cell Lymphoma | Recruiting |
| NCT05848765 | Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | Relapsed Follicular Lymphoma | Recruiting |
| NCT06561347 | Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM | Waldenstrom Macroglobulinemia | Recruiting |
| NCT06425302 | A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab… | Lymphoma, Follicular | Active, Not Recruiting |
| NCT04624906 | Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia | Waldenstrom Macroglobulinemia | Active, Not Recruiting |
| NCT03755804 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | Hodgkin Lymphoma | Active, Not Recruiting |